As of June 21, 2025, Bionik Laboratories Corp (BNKL) reports a EV/EBITDA of -0.62.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing Bionik Laboratories Corp's EV/EBITDA to Peers
To better understand Bionik Laboratories Corp's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| Bionik Laboratories Corp (BNKL) | -0.62 |
| Ingen Technologies Inc (IGNT) | 13.20 |
| American Bio Medica Corp (ABMC) | 0.11 |
| Aethlon Medical Inc (AEMD) | 0.09 |
| Speedus Corp (SPDE) | -0.02 |
| Stock Trend Capital Inc (PUMP.CN) | -0.67 |
Compared to its competitors, Bionik Laboratories Corp's EV/EBITDA is about average compared to peers, indicating market valuation in line with industry expectations.